BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37310516)

  • 1. Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer.
    Wang Y; McCarthy AL; Tuffaha H
    Support Care Cancer; 2023 Jun; 31(7):391. PubMed ID: 37310516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise in preventing falls for men with prostate cancer: a modelled cost-utility analysis.
    Edmunds K; Scuffham P; Newton RU; Galvão DA; Tuffaha H
    Support Care Cancer; 2022 Jun; 30(6):5037-5046. PubMed ID: 35201385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness Analysis of Supervised Exercise Training in Men with Prostate Cancer Previously Treated with Radiation Therapy and Androgen-Deprivation Therapy.
    Edmunds K; Reeves P; Scuffham P; Galvão DA; Newton RU; Jones M; Spry N; Taaffe DR; Joseph D; Chambers SK; Tuffaha H
    Appl Health Econ Health Policy; 2020 Oct; 18(5):727-737. PubMed ID: 32107736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis.
    Ying T; Tran A; Webster AC; Klarenbach SW; Gill J; Chadban S; Morton R
    Am J Kidney Dis; 2020 May; 75(5):693-704. PubMed ID: 31810731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
    Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
    Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: An Australian perspective.
    Ademi Z; Zomer E; Tonkin A; Liew D
    Int J Cardiol; 2018 Nov; 270():54-59. PubMed ID: 30220379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
    Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
    Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective.
    Ademi Z; Pasupathi K; Liew D
    Medicine (Baltimore); 2016 May; 95(18):e3531. PubMed ID: 27149456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.
    Armeni P; Borsoi L; Fornaro G; Jommi C; Colombo N; Costa F
    Clin Ther; 2020 Jul; 42(7):1192-1209.e12. PubMed ID: 32591103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.
    Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E
    Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity.
    Chowdhury EK; Ademi Z; Moss JR; Wing LMH; Reid CM;
    Medicine (Baltimore); 2015 Mar; 94(9):e590. PubMed ID: 25738481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cost-effectiveness of home versus clinic-based management of chronic heart failure: the WHICH? study.
    Maru S; Byrnes JM; Carrington MJ; Stewart S; Scuffham PA
    J Med Econ; 2017 Apr; 20(4):318-327. PubMed ID: 27841726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer.
    Orellana TJ; Kim H; Beriwal S; Bhargava R; Berger J; Buckanovich RJ; Coffman LG; Courtney-Brooks M; Mahdi H; Olawaiye AB; Sukumvanich P; Taylor SE; Smith KJ; Lesnock JL
    Gynecol Oncol; 2022 Jan; 164(1):129-135. PubMed ID: 34740462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Offering a lifestyle intervention to women of premenopausal age as primary prevention for cardiovascular disease? - assessing its cost-effectiveness.
    Gao L; Moodie M
    Int J Behav Nutr Phys Act; 2022 Dec; 19(1):152. PubMed ID: 36517831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of supervised exercise therapy in heart failure patients.
    Kühr EM; Ribeiro RA; Rohde LE; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S100-7. PubMed ID: 21839879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.